Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › Texas
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials in Texas
8 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are looking for participants at sites in Texas.
Cities in Texas
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- MD Anderson Cancer Center, Houston
- Sarah Cannon Transplant and Cellular Therapy Methodist Hospital, San Antonio
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
- MD Anderson Cancer Center, Houston
RecruitingPhase 2
1 Month – 21 Years · All sexes · Updated Sep 18, 2026 · NCT06561074Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Up to age 39 · All sexes · Updated Sep 11, 2026 · NCT04972942Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
- UT MD Anderson, Houston
RecruitingPhase 1
Ages 12 to 30 · All sexes · Updated Aug 12, 2026 · NCT07513129Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
RecruitingPhase 1
Up to age 75 · All sexes · Updated Aug 11, 2026 · NCT03081910Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- M D Anderson Cancer Center, Houston
RecruitingPhase 2
All ages · All sexes · Updated Jul 15, 2026 · NCT00501826A Registry for People With T-cell Lymphoma
- MD Anderson Cancer Center (Data Collection Only), Houston
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
RecruitingPhase 1
Up to age 75 · All sexes · Updated May 18, 2026 · NCT07220993From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.